Revised U.S. Guidelines on Hepatitis B Vaccination Could Lead to Increased Infections and Healthcare Costs, Research Indicates - Takeaways - MDSpire

Revised U.S. Guidelines on Hepatitis B Vaccination Could Lead to Increased Infections and Healthcare Costs, Research Indicates

  • By

  • Helen Branswell

  • April 27, 2026

  • 0 min

Share

  • 1

    New U.S. guidelines recommend hepatitis B vaccination at birth only for at-risk infants, potentially increasing infections and healthcare costs.

  • 2

    Studies project that delaying the first hepatitis B vaccine dose could lead to 90 additional infections and over $16 million in extra healthcare costs annually.

  • 3

    The new policy may result in confusion and lower vaccination rates due to lack of a universal birth dose recommendation.

  • 4

    Experts warn that the targeted vaccination approach could lead to more chronic hepatitis B cases among children.

  • 5

    The Advisory Committee on Immunization Practices' decision has faced legal challenges and criticism from public health experts.

Original Source(s)

Revised U.S. Guidelines on Hepatitis B Vaccination Could Lead to Increased Infections and Healthcare Costs, Research Indicates

  • by Helen Branswell

  • April 27, 2026

Related Content

Parenteral neonatal priming followed by heterologous mucosal booster favors IgM+ memory B cell induction over systemic plasma cell differentiation

HPV Vaccine Uptake Varied Widely Across US States

Analysis of more than 16,000 US adolescents found substantial variation in HPV vaccination uptake both across and within census regions

Correction: One hundred years of BCG: the journey of tuberculosis vaccination in Brazil